CRISPR Therapeutics AG

CRSP · NASDAQ

$49.88−$0.16 (−0.32%)TodayMarket closed · Oct 20, 7:58 PM ET

Prev close $50.04

Latest news

NewsOct 6, 4:08 AM ETRishabh Mishra
Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison’
NewsSep 7, 2:46 AM ETRishabh Mishra
Cathie Wood Says AI Revolution Could Supercharge Global Growth — TSLA, COIN and CRSP Stocks Are Among Her Top Bets
NewsSep 1, 12:25 PM ETChandrima Sanyal
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
NewsAug 20, 5:59 AM ETMohd Haider
Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why
NewsAug 19, 11:29 PM ETMohd Haider
Moderna Stock Cools Off After-Hours, Following Massive 177% Cancer Vaccine Rally — Merck, Pfizer and BioNTech Among mRNA Names Trending Tonight
Press releaseAug 3, 4:15 PM ETGlobe Newswire
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
NewsJun 21, 5:46 PM ETCrispus Nyaga
Investors Flee Cathie Wood's ARKK ETF As It Trails S&P 500, Nasdaq 100 By Far
Press releaseMay 14, 9:00 AM ETPRNewswire
A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Avaí Bio's Cell-Based Platform Approach
Press releaseMay 4, 4:30 PM ETGlobe Newswire
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
Press releaseMar 30, 9:15 AM ETGlobe Newswire
Legendary Investors are Rotating Capital into AI Powered Biotech
Press releaseMar 24, 11:05 AM ETPRNewswire
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning
NewsMar 10, 12:56 PM ETNabaparna Bhattacharya
What's Going On With CRISPR Therapeutics Stock Today?
NewsMar 9, 1:32 PM ETVandana Singh
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
NewsFeb 26, 1:45 PM ETKaustubh Bagalkote
Why Is CRISPR Therapeutics Stock Surging Thursday?
Press releaseFeb 25, 9:00 AM ETPRNewswire
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
NewsFeb 12, 4:42 PM ET
CRISPR Therapeutics Earnings Report: Q4 Overview
Press releaseFeb 12, 4:30 PM ETGlobe Newswire
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Press releaseJan 28, 8:05 AM ETGlobe Newswire
Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine
Press releaseJan 12, 8:36 AM ETGlobe Newswire
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones
NewsJan 7, 9:17 AM ETVandana Singh
Positive China Trial Data Moves HUTCHMED Closer To Rare Blood Disorder Drug Filing In 2026
Press releaseJan 2, 1:29 PM ETPRNewswire
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
NewsDec 31, 5:06 PM ETErica Kollmann
Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks
Press releaseDec 22, 8:30 AM ETGlobe Newswire
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
Press releaseDec 16, 12:00 PM ETGlobe Newswire
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
Press releaseDec 9, 11:57 AM ETPRNewswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Press releaseNov 19, 10:06 AM ETGlobe Newswire
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
NewsNov 6, 1:55 PM ET
FDA Awards Second Batch of National Priority Vouchers
NewsNov 4, 8:42 PM ETShivdeep Dhaliwal
Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys
NewsOct 27, 10:38 AM ETAkanksha Bakshi
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles
NewsOct 8, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session
Press releaseOct 2, 7:00 AM ETBusiness Wire
Australia's Largest University Establishes 'Monash Boston Hub' to Accelerate Global Biotech Partnerships and Licensing
Press releaseSep 18, 8:45 AM ETPRNewswire
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
NewsSep 2, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session
NewsAug 19, 11:40 AM ETPiero Cingari
Cathie Wood's ARKK Is Beating Big Tech Like It's 2020 Again — But With A Twist
NewsAug 5, 9:48 PM ETShivdeep Dhaliwal
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results
NewsJul 26, 1:25 AM ETRounak Jain
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
NewsJul 18, 10:03 AM ETAvi Kapoor
Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday
NewsJul 10, 1:22 PM ETDylan Berman
CRISPR Stock Surges in Recent Weeks: What's Going On?
Press releaseJul 9, 8:30 AM ETPRNewswire
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
NewsJul 8, 2:24 AM ETVishaal Sanjay
Cathie Wood-Led Ark Launches Buffer ETFs For Its Flagship ARKK, Analyst Says It's Like Diet Soda — 50% Loss Protection, But There's A Catch
NewsJun 20, 1:59 PM ETVandana Singh
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
NewsMay 7, 8:39 AM ETAvi Kapoor
These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results
NewsApr 30, 10:36 PM ETShivdeep Dhaliwal
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison’

Cathie Wood Says AI Revolution Could Supercharge Global Growth — TSLA, COIN and CRSP Stocks Are Among Her Top Bets

Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why

Moderna Stock Cools Off After-Hours, Following Massive 177% Cancer Vaccine Rally — Merck, Pfizer and BioNTech Among mRNA Names Trending Tonight

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

Investors Flee Cathie Wood's ARKK ETF As It Trails S&P 500, Nasdaq 100 By Far

A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Avaí Bio's Cell-Based Platform Approach

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Legendary Investors are Rotating Capital into AI Powered Biotech

Anti-Aging Protein Research Takes a Step Forward with Cell Cloning

What's Going On With CRISPR Therapeutics Stock Today?

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

Why Is CRISPR Therapeutics Stock Surging Thursday?

Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026

CRISPR Therapeutics Earnings Report: Q4 Overview

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

Positive China Trial Data Moves HUTCHMED Closer To Rare Blood Disorder Drug Filing In 2026

Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize

Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks

CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions

The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care

FDA Awards Second Batch of National Priority Vouchers

Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys

Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles

10 Health Care Stocks Whale Activity In Today's Session

Australia's Largest University Establishes 'Monash Boston Hub' to Accelerate Global Biotech Partnerships and Licensing

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

10 Health Care Stocks Whale Activity In Today's Session

Cathie Wood's ARKK Is Beating Big Tech Like It's 2020 Again — But With A Twist

Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics

Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday

CRISPR Stock Surges in Recent Weeks: What's Going On?

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

Cathie Wood-Led Ark Launches Buffer ETFs For Its Flagship ARKK, Analyst Says It's Like Diet Soda — 50% Loss Protection, But There's A Catch

FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant